Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2016 1
2018 5
2019 3
2020 3
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean jubran ahmed (9 results)?
Blood-based multi-cancer detection: A state-of-the-art update.
Farooq M, Leevan E, Ahmed J, Ko B, Shin S, De Souza A, Takebe N. Farooq M, et al. Among authors: ahmed j. Curr Probl Cancer. 2024 Feb;48:101059. doi: 10.1016/j.currproblcancer.2023.101059. Epub 2024 Jan 5. Curr Probl Cancer. 2024. PMID: 38181630 Review.
Aesthetic finger prosthesis.
Shanmuganathan N, Maheswari MU, Anandkumar V, Padmanabhan TV, Swarup S, Jibran AH. Shanmuganathan N, et al. Among authors: jibran ah. J Indian Prosthodont Soc. 2011 Dec;11(4):232-7. doi: 10.1007/s13191-011-0074-9. Epub 2011 Jun 21. J Indian Prosthodont Soc. 2011. PMID: 23204732 Free PMC article.
Learning From Failure: Negative Trials in Oncology.
Nardo M, Guven DC, Yikilmaz AS, Singh S, Ahmed J. Nardo M, et al. Among authors: ahmed j. J Immunother Precis Oncol. 2023 Apr 12;6(2):59-60. doi: 10.36401/JIPO-23-X1. eCollection 2023 May. J Immunother Precis Oncol. 2023. PMID: 37214208 Free PMC article. No abstract available.
Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.
Knisely A, Ahmed J, Stephen B, Piha-Paul SA, Karp D, Zarifa A, Fu S, Hong DS, Rodon Ahnert J, Yap TA, Tsimberidou AM, Alshawa A, Dumbrava EE, Yang Y, Song J, Meric-Bernstam F, Jazaeri AA, Naing A. Knisely A, et al. Among authors: ahmed j. Cancer. 2024 Feb 1;130(3):400-409. doi: 10.1002/cncr.35063. Epub 2023 Oct 21. Cancer. 2024. PMID: 37864520 Clinical Trial.
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.
Nelson BE, Roszik J, Ahmed J, Barretto CMN, Nardo M, Campbell E, Johnson AM, Piha-Paul SA, Oliva ICG, Weathers SP, Cabanillas M, Javle M, Meric-Bernstam F, Subbiah V. Nelson BE, et al. Among authors: ahmed j. Mol Cancer. 2024 Mar 26;23(1):64. doi: 10.1186/s12943-024-01982-4. Mol Cancer. 2024. PMID: 38532456 Free PMC article.
18 results